Literature DB >> 6278019

Antibody to cytomegalovirus in Malta.

L J Spiteri, R Chamberlain, R Pollard, J O Tobin.   

Abstract

Antibody to cytomegalovirus (CMV) was sought in sera from Malta using immunofluorescence. Seven per cent of the infants, 36% of the school children, increasing to 100% of the adults aged over 40 years were found to have antibody. Most infection occurred in pre-school children and adults over 25 years of age. This pattern of antibody acquisition appears different from that described for other countries.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6278019      PMCID: PMC2133852          DOI: 10.1017/s0022172400070200

Source DB:  PubMed          Journal:  J Hyg (Lond)        ISSN: 0022-1724


  7 in total

1.  THE INCIDENCE OF INFECTION WITH CYTOMEGALOVIRUS IN A NORMAL POPULATION. A SEROLOGICAL STUDY IN GREATER LONDON.

Authors:  H STERN; S D ELEK
Journal:  J Hyg (Lond)       Date:  1965-03

2.  Identification of pregnancies at risk from cytomegalovirus infection.

Authors:  L M de Silva; G L Kampfner; C M Lister; J O Tobin
Journal:  J Hyg (Lond)       Date:  1977-12

3.  Complement-fixing antibodies against cytomegalovirus in different parts of the world.

Authors:  U Krech
Journal:  Bull World Health Organ       Date:  1973       Impact factor: 9.408

4.  A study of complement-fixing, immunofluorescent, and neutralizing antibodies in human cytomegalovirus infections.

Authors:  U Krech; M Jung; W Sonnabend
Journal:  Z Immunitatsforsch Exp Klin Immunol       Date:  1971-06

5.  School failure and deafness after "silent" congenital cytomegalovirus infection.

Authors:  J B Hanshaw; A P Scheiner; A W Moxley; L Gaev; V Abel; B Scheiner
Journal:  N Engl J Med       Date:  1976-08-26       Impact factor: 91.245

6.  A collaborative study of cytomegalovirus antibodies in mothers and young children in 19 countries.

Authors:  U Krech; J Tobin
Journal:  Bull World Health Organ       Date:  1981       Impact factor: 9.408

7.  Primary infection with human cytomegalovirus: virus isolation from healthy infants and pregnant women.

Authors:  Y Numazaki; N Yano; T Morizuka; S Takai; N Ishida
Journal:  Am J Epidemiol       Date:  1970-04       Impact factor: 4.897

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.